Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
Netanyahu orders deeper Israeli incursion into Lebanon
US military says it turned away blockade runner trying to reach Iranian port
Illegal mine collapses in China, killing five just days after Shanxi disaster
Israel troops capture Beaufort Castle in southern Lebanon push against Hezbollah
Jubilant PSG supporters spill onto Paris streets, some clash with police
